title: Clinical and laboratory changes following plasmapheresis in 12 patients with squamous cancer of the head and neck.
authors.affiliation: VA Medical Center, Boston, MA 02130.
authors.forename: R H
authors.initials: RH
authors.lastname: Seder
authors.forename: C W
authors.initials: CW
authors.lastname: Vaughan
authors.forename: A E
authors.initials: AE
authors.lastname: Katz
authors.forename: G C
authors.initials: GC
authors.lastname: Blanchard
authors.forename: F
authors.initials: F
authors.lastname: Ulrich
authors.forename: S K
authors.initials: SK
authors.lastname: Oh
authors.forename: B L
authors.initials: BL
authors.lastname: Willett
authors.forename: D D
authors.initials: DD
authors.lastname: Karp
authors.forename: W G
authors.initials: WG
authors.lastname: Doos
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D003131:Combined Modality Therapy; D006258:Head and Neck Neoplasms / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D007070:Immunoglobulin A / Q000378:metabolism; D007073:Immunoglobulin E / Q000378:metabolism; D010956:Plasmapheresis; D013491:Suppressor Factors, Immunologic / Q000097:blood / Q000302:isolation & purification
chemical_list: D007070:Immunoglobulin A; D013491:Suppressor Factors, Immunologic; D007073:Immunoglobulin E